RecruitingNCT05973786

The Effect of a Six Week Intensified Pharmacological Treatment for Depression in bipolarity Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.

Medication studyAges 18+Multiple countries

The study in practice

Understand this study

This study is for people with bipolarity. Listed age limits: from 18 years. Other eligibility criteria apply.

Listed locations: Innsbruck and 12 more locationsSee all locations and recruitment
Study phase: Phase 3

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Study start dateStarted: February 11, 2025

Recruitment status: Recruiting
Enrollment listed in the registry: 418
Sponsor: Dr. Inge Winter
Sponsor type: Individual investigator
Study type: Drug
Intervention type: Drug
Study phase: Phase 3
Locations: United Kingdom, Austria, Germany, ...
Age range: Over 18 Years
Official registry ID: NCT05973786
Official title: Show the full official title
A Randomised, Controlled Trial to Investigate the Effect of a Six Week Intensified Pharmacological Treatment for Bipolar Depression Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.

Currently recruiting

Innsbruck, Austria · Bielefeld, Germany · Dortmund, Germany

10 more locations

FAQ

Who is behind this study?

The study sponsor is Dr. Inge Winter.

Does this study involve medication?

Yes. The study involves medication, including Escitalopram, Sertraline, Venlafaxine, lithium, Valproate acid, Quetiapine and Bupropion.

Who can participate?

This study is for people with bipolarity. Listed age limits: from 18 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as recruiting.